Stocks and Investing
Stocks and Investing
Tue, February 27, 2024
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
Mon, February 26, 2024
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
Michael Cherny Initiated (TDOC) at Hold and Held Target at $17 on, Feb 26th, 2024
Michael Cherny of Leerink Partners, Initiated "Teladoc Health, Inc." (TDOC) at Hold and Held Target at $17 on, Feb 26th, 2024.
Michael has made no other calls on TDOC in the last 4 months.
There are 7 other peers that have a rating on TDOC. Out of the 7 peers that are also analyzing TDOC, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Daniel Grosslight of "Citigroup" Maintained at Hold with Decreased Target to $19 on, Wednesday, February 21st, 2024
- Gil Luria of "DA Davidson" Maintained at Hold with Decreased Target to $18 on, Wednesday, February 21st, 2024
- Lisa Gill of "JP Morgan" Maintained at Hold with Decreased Target to $19 on, Friday, November 17th, 2023
These are the ratings of the 4 analyists that currently disagree with Michael
- Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $25 on, Wednesday, February 21st, 2024
- Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $28 on, Wednesday, February 21st, 2024
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $25 on, Wednesday, February 21st, 2024
- Steve Valiquette of "Barclays" Maintained at Buy with Decreased Target to $25 on, Wednesday, February 21st, 2024
Contributing Sources